CSRXP STATEMENT ON PROPOSED CMS COVERAGE DECISION FOR ADUHELM
Jan 12, 2022
DECISION WILL HELP PROTECT SENIORS, TAXPAYERS AND THE U.S. HEALTH SYSTEM FROM… Read More
© 2026 CSRXP- All Rights Reserved
Statements
CSRXP STATEMENT ON U.S. SENATE PASSAGE OF REBATE RULE DELAY & REFUND ACT AS PART OF BIPARTISAN INFRASTRUCTURE BILL
Aug 10, 2021
Lawmakers Must Build on Momentum For Action With Permanent Repeal of Rebate… Read More
CSRxP COMMENDS PRESIDENT BIDEN FOR RENEWED COMMITMENT TO HOLDING BIG PHARMA ACCOUNTABLE
Jul 9, 2021
Campaign Looks Forward to Working with Administration and Congress to Crack… Read More
CSRXP COMMENDS PRESIDENT BIDEN FOR RENEWING COMMITMENT TO LOWERING PRESCRIPTION DRUG PRICES IN BUDGET
May 28, 2021
Time for the Administration and Congress to Convert Promises Made Into… Read More
CSRXP WELCOMES U.S. SENATE HEARING ON OUT-OF-CONTROL PRESCRIPTION DRUG PRICES
Mar 22, 2021
Lawmakers on HELP Subcommittee Can Add to Bipartisan Momentum to Hold Big… Read More
CSRXP COMMENDS LAWMAKERS FOR REFOCUSING CRITICAL ATTENTION ON BIG PHARMA’S EGREGIOUS PRICE HIKES AND PRACTICES
Sep 30, 2020
House Committee on Oversight and Reform to Question Big Pharma Executives… Read More
CSRxP Commends Congressional Probe Of Big Pharma Giant’s Anti-Competitive Tactics and Egregious Pricing Practices
Sep 1, 2020
U.S. House Oversight Committee Subpoena of AbbVie Related to Pricing of… Read More
CSRXP APPLAUDS INCLUSION OF CREATES IN SPENDING DEAL; URGES CONGRESS TO KEEP WORKING TO HOLD BIG PHARMA ACCOUNTABLE, LOWER Rx PRICES
Dec 16, 2019
Passage of Bipartisan, Market-based CREATES Act Will Be A First Step in the… Read More
CSRXP APPLAUDS USMCA CHANGES TO PUT AMERICAN PATIENTS FIRST
Dec 10, 2019
Revisions to Historic Trade Deal Remove Big Pharma Carveout Washington… Read More
CSRxP Commends Administration for Commitment to DTC Advertising Rule
Aug 21, 2019
Applauds HHS For Appealing Ruling Against List Price Transparency Measure… Read More
Insulin Hearing Will Add To Drug Pricing Momentum On Capitol Hill
Apr 1, 2019
CSRxP Commends House Energy & Commerce Committee For Giving Voice To… Read More
CSRxP Statement on Potential Big Pharma Bailout
Sep 21, 2018
“Only Big Pharma would use bipartisan opioid legislation as another… Read More